Why the study?
Does ACE inhibitor therapy improve quality of life in patients with chronic heart failure secondary to reduced left ventricular systolic function?
Population
Patients with chronic heart failure secondary to reduced left ventricular systolic function
Comparison
ACE inhibitors (including enalapril and ramipril) vs Placebo
Design
Review
Authors
Loading...
Long-term HRQL benefits of ACE inhibitors in HFrEF remain uncertain; leaves open dedicated prospective QoL trials.
Does ACE inhibitor therapy improve quality of life in patients with chronic heart failure secondary to reduced left ventricular systolic function?
ACE inhibitors do not compromise and may improve certain components of quality of life in patients with chronic heart failure with reduced ejection fraction, alongside their known survival benefits.
Eugene E. Wolfel (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: